ORAL SQUAMOUS CELL CARCINOMA
Clinical trials for ORAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ORAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ORAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Glow-in-the-dark mouth exam could catch cancer earlier
Diagnosis CompletedThis study tested whether a special light (autofluorescence) can help doctors spot early signs of mouth cancer in people who smoke and drink heavily. 180 adults hospitalized for alcohol withdrawal took part. The goal was to see if the light technique is more reliable than a stand…
Matched conditions: ORAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
New scanner could help surgeons spot Left-Behind cancer Mid-Operation
Diagnosis CompletedThis study tested a new type of PET-CT scanner that can scan a tumor right after it is removed from the body. Patients with prostate or head and neck cancer received a small amount of radioactive tracer before surgery, which sticks to cancer cells. After removal, the specimen was…
Matched conditions: ORAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: University Hospitals Coventry and Warwickshire NHS Trust • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Could a laser beam stop chemo mouth sores?
Prevention CompletedThis trial investigates whether a low-level diode laser can prevent or reduce severe mouth sores (mucositis) caused by radiation and chemotherapy in people with advanced head and neck cancer. Participants receive either real laser therapy or a non-functional placebo laser during …
Matched conditions: ORAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Institut Cancerologie de l'Ouest • Aim: Prevention
Last updated Jul 02, 2026 07:00 UTC
-
Could a seed protein stop oral cancer? early study hints at promise
Knowledge-focused CompletedThis early-phase study looked at whether a protein from the Maackia amurensis seed (MASL) can target a receptor called podoplanin found on oral cancer and precancerous cells. Researchers measured how much of this receptor was present in tissue samples from 18 adults with suspicio…
Matched conditions: ORAL SQUAMOUS CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Rowan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC